Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00227721
Status:
COMPLETED
Last Update Posted:
2020-12-02
First Post:
2005-09-26
Brief Title:
Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer
Sponsor:
Organization:
Barbara Ann Karmanos Cancer Institute